GE Healthcare to Host Scientific Meeting

Attended by leading scientists from both academia and industry, the conference will address many key challenges facing the industry, such as how label-free binding studies can advance fragment based drug discovery and how label-free detection can provide the insights needed to drive progress in biotherapeutic development.

The conference is comprised of educational and scientific sessions, including key lectures, workshops, and round-table sessions covering the latest advances and new solutions. The scientific sessions highlight three forefront topics:

• Fragment and small molecule screening and characterization

Keynote speaker: Tony Giannetti, Genentech, USA.
The short history of fragment based lead discovery and the impact of the quantitative optical biosensor.

• Biotherapeutic and vaccine discovery and development

Keynote Speaker: Indresh Srivastava, NIH, USA.
Biophysical characterization of vaccines

• Structure-activity relationship

Keynote speaker: David Wilson, Georgia State University, USA.
Biosensor-SPR and ITC applications to nucleic acid Interactions: New approaches and biological applications

Delegates will also have the opportunity to take part in pre-conference tutorials addressing the use of Biacore™, MicroCal™ ITC and MicroCal DSC systems, as well as workshops providing educational and practical information on a range of application and methodology-related topics.